Graham Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Buy |
9,886
+3,921
| +66% | +$256K | 0.01% | 679 |
|
|
2025
Q1 | $399K | Sell |
5,965
-393
| -6% | -$26.3K | 0.01% | 865 |
|
|
2024
Q4 | $351K | Buy |
+6,358
| New | +$351K | 0.01% | 839 |
|
|
2024
Q2 | – | Sell |
-3,334
| Closed | -$230K | – | 1002 |
|
|
2024
Q1 | $230K | Sell |
3,334
-1,763
| -35% | -$122K | ﹤0.01% | 839 |
|
|
2023
Q4 | $281K | Sell |
5,097
-6,869
| -57% | -$379K | 0.01% | 720 |
|
|
2023
Q3 | $695K | Buy |
11,966
+7,447
| +165% | +$432K | 0.02% | 448 |
|
|
2023
Q2 | $243K | Buy |
+4,519
| New | +$243K | 0.01% | 747 |
|
|
2023
Q1 | – | Sell |
-8,744
| Closed | -$352K | – | 1028 |
|
|
2022
Q4 | $352K | Buy |
+8,744
| New | +$352K | 0.01% | 840 |
|